Her primary scientific interests are in Immunology, Molecular biology, Interleukin 9, T cell and Antigen. She integrates Immunology with Indoleamine 2,3-dioxygenase in her study. Her study in Molecular biology is interdisciplinary in nature, drawing from both Tyrosine kinase, JAK-STAT signaling pathway, Interleukin-21 receptor and Complementary DNA, Molecular cloning.
The Interleukin 9 study combines topics in areas such as Cell biology, Growth factor and Interleukin 4. Her T cell study incorporates themes from Cytotoxic T cell and B cell. Her biological study spans a wide range of topics, including Epitope, Toxicity and Enzyme.
Catherine Uyttenhove mostly deals with Immunology, Molecular biology, Antigen, Immune system and Cancer research. Her Immunology study is mostly concerned with Antibody, Cytokine, Interleukin 17, T cell and Vaccination. Her Antibody study combines topics in areas such as Experimental autoimmune encephalomyelitis and Interleukin 12.
Her Molecular biology research also works with subjects such as
Her scientific interests lie mostly in Immunology, Cancer research, Immune system, Antibody and Cancer. Inflammation, Interleukin 17, T cell, Neutralization and Cancer immunotherapy are the core of her Immunology study. She combines subjects such as CD8, Molecular biology, Graft-versus-host disease, Regulatory T cell and Cytotoxic T cell with her study of Cancer research.
Her work carried out in the field of Immune system brings together such families of science as DNA and Arthritis. Her work in Antibody addresses subjects such as Interleukin 12, which are connected to disciplines such as Mastocytoma and Immune protection. Her Cancer study combines topics from a wide range of disciplines, such as Transforming growth factor, Melanoma, Cytolysis and Virus.
Catherine Uyttenhove focuses on Immunology, Cancer research, Inflammation, Molecular biology and Lung. The various areas that Catherine Uyttenhove examines in her Immunology study include Cancer and Melanoma. Her biological study spans a wide range of topics, including Immunohistochemistry, Cell, Cell migration and Cytotoxic T cell, Tumor antigen.
Catherine Uyttenhove works mostly in the field of Inflammation, limiting it down to topics relating to Cytokine and, in certain cases, Mesenteric lymph nodes, Intracellular parasite, Intracellular and Immunopathology, as a part of the same area of interest. Her work deals with themes such as B cell, Integrin, Periostin, Cell adhesion molecule and Monoclonal antibody, which intersect with Molecular biology. Her Lung research incorporates elements of Respiratory tract, Respiratory system and Polyethylene glycol, PEGylation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
Catherine Uyttenhove;Luc Pilotte;Ivan Théate;Ivan Théate;Vincent Stroobant.
Nature Medicine (2003)
Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset
Marc Veldhoen;Catherine Uyttenhove;Jacques van Snick;Helena Helmby.
Nature Immunology (2008)
Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.
J Van Snick;S Cayphas;A Vink;C Uyttenhove.
Proceedings of the National Academy of Sciences of the United States of America (1986)
Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice
David Bending;Hugo De La Peña;Marc Veldhoen;Jenny M. Phillips.
Journal of Clinical Investigation (2009)
IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells
Wassim Elyaman;Elizabeth M. Bradshaw;Catherine Uyttenhove;Valérie Dardalhon.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte;Pierre Larrieu;Vincent Stroobant;Didier Colau.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
Soraya Taleb;Mélissa Romain;Bhama Ramkhelawon;Catherine Uyttenhove.
Journal of Experimental Medicine (2009)
B cell depletion reduces the development of atherosclerosis in mice
Hafid Ait-Oufella;Olivier Herbin;Jean-David Bouaziz;Jean-David Bouaziz;Christoph J. Binder.
Journal of Experimental Medicine (2010)
Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity
C Uyttenhove;R J Simpson;J Van Snick.
Proceedings of the National Academy of Sciences of the United States of America (1988)
Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9).
Lothar Hültner;Catherine Druez;Jochen Moeller;Catherine Uyttenhove.
European Journal of Immunology (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: